Logo

Lifecode

Vela Diagnostics Acquires Lifecode Data Interpretation Division

The deal, which comes about three months after Lifecode's acquisition by MedGenome, marks Vela's first foray into the genomic data interpretation market.

MedGenome Acquires Lifecode Health

The acquisition will give India's MedGenome access to a CLIA-certified and CAP-accredited laboratory in the Bay Area so that it can expand its operations in the US.

NGS-based Cancer MDx Firm Lifecode Raises $20.5M, Receives CAP Accreditation

The previously undisclosed Series A Round financing was led by Sequoia Capital, Mayo Clinic, and Mayo Ventures. 

Breaking News
The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.